Diligence memo · auto-generated · as of July 3, 2026
Atraverse Medical, Inc.
Atraverse Medical, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Atraverse Medical, Inc. operates in Healthtech, based in Cardiff by the Sea.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Atraverse Medical, Inc. has raised $33M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $15M on 2025-02-13.
Most recent recorded round closed around 2025-04-23.
Valuation (modeled)modeled
Provath models Atraverse Medical, Inc. at approximately $32M (range $11M–$57M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.65× the median modeled value of Series A Healthtech companies in 2025–2027 (99 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 5 months.
Last raise 14 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 1.7× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 86% of Healthtech peers (2138 compared).
Modeled value ranks above 53% of those peers.
Closest niche peers: Queen Dental USA Inc, Healthplan Data Solutions, Inc., Chronic Care Management, Inc., Mountain Health Technologies, Inc., Modular Medical, Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.